Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.

about

Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.

Item

http://www.wikidata.org/entity/Q36013973

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.

@ast

Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.

@en

type

Item

label

Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.

@ast

Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.

@en

prefLabel

Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.

@ast

Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.

@en

P1476

Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.

@en

P2093

Abiola Ojo

http://www.w3.org/2001/XMLSchema#string

Jateh Major

http://www.w3.org/2001/XMLSchema#string

Oluwaranti Akiyode

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.

Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.

Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy

Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months.

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study.

P31

scholarly article

review article

P356

10.1177/0897190016647232

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27166390

http://www.w3.org/2001/XMLSchema#string